Dark

KALA
KALA BIO, Inc. Common Stock
stock NASDAQ

At Close

Jan 30, 2026 3:59:30 PM EST

0.5250USD-2.787%(-0.0151)522,360

0.00Bid 0.00Ask 0.0000Spread

Pre-market

Jan 30, 2026 9:22:30 AM EST

0.5234USD-3.074%(-0.0166)8,084

After-hours

Jan 29, 2026 4:36:30 PM EST

0.5330USD+0.038%(0.0000)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

14.52M

CEO

Mark Iwicki

Headquarters

Watertown, Massachusetts, USA

Industry

Drug Manufacturers-Specialty & Generic

Last Split

Oct 21, 20221for50reverse

OMER XLV

KALA Stats

Avg. Vol. 10 Day

1,102,336

Avg. Vol. 30 Day

1,987,247

Employees

Market Cap

14,518,062

Shares Out.

27,849,725

On/Off Exchange

35%/65%

6 Month Beta

1.17

1 Year Beta

1.15

2 Year Beta

1.05

3 Year Beta

1.20

52 Week Low

0.51

52 Week High

20.60

SMA50

0.68

SMA200

4.53

1 Week

-10.41%

1 Month

-16.07%

3 Month

-33.17%

6 Month

-93.05%

1 Year

-94.33%

2 Year

-92.42%

5 Year

-99.86%

Profile

kala pharmaceuticals, inc. (kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based mucus penetrating particles, or mpp, technology, with an initial focus on the treatment of eye diseases. for more information, please visit kala's website at www.kalarx.com.

KALA Stock Summary

KALA BIO, Inc. Common Stock (NASDAQ:KALA) stock price today is $0.5250, and today's volume is 522,360. KALA is down -2.787% today. The 30 day average volume is 1,987,247. KALA market cap is 14.52M with 27,849,725 shares outstanding.